Smoking Asthmatics Cohort Study
The American Lung Association Asthma Clinical Research Center (ACRC) network is examining whether asthma control assessment measures and treatment options work as well in those who smoke.
Asthma is a common lung disease that makes breathing difficult for over 25 million Americans; 20-30 percent of whom also currently smoke. While there is no cure for asthma, the disease can be managed and treated in most individuals allowing them to live a normal, healthy life. However, evidence suggests that the current asthma treatment guidelines may not be appropriate for smokers with research indicating that inhaled corticosteroids, the recommended mainstay for treating persistent asthma, being less effective in smokers.
As such, the ACRC is looking at current cigarette smokers with poorly controlled asthma in the Smoking Asthmatics Cohort Study (SCS) to evaluate whether asthma control assessment measures are as effective when used with smoking asthmatics as they are with non-smoking asthmatics.
"If we find that these assessment measures are valid in smokers, we will then be able to examine whether certain add-on therapies can benefit poorly-controlled smoking asthmatics," said Joe Ramsdell, M.D., primary investigator of the SAPS trial at the American Lung Association Asthma Clinical Research Center located at the University of California, San Diego. "It is hoped that our research will lead to improved asthma care for smokers."
In addition, the ACRC at the University of San Diego is conducting the Smoking Asthmatics Pilot Study (PILOT), a trial that is evaluating treatment options for asthmatics who smoke cigarettes. This trial is being done to assess the feasibility of doing a larger trial in asthmatics who smoke. For the Pilot study, they are recruiting current smokers between the ages of 18-50 for a 6 month trial. To learn more about the PILOT at UCSD, call 888-UCSD-AIR.